I think GC should stop tweeting company info. It allows the flippers to play this stock like a drum and leave longs as bag holders. Uncertainty, unpredictability are what flippers cant stand. True longs like myself are here for the long haul. So we need a methodic, slow and steady progress of company and pps. Rather to speak for myself that is what i want. Lympro to me is side kick, the real dish is MANF. It would be great if lympro could generate enough revenue to fund the money hungry steps associated with MANF future clinical trials... if not so be it..
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links